Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.
Leukocyte Gene Expression and Plasma Concentration in Multiple Sclerosis: Alteration of Transforming Growth Factor-βs, Claudin-11, and Matrix Metalloproteinase-2.
Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome.
Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
High nationwide incidence of multiple sclerosis in sweden.
Multiparity in women with multiple sclerosis causes less long-term disability: Commentary.
Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms.
Resveratrol Promotes Remyelination in Cuprizone Model of Multiple Sclerosis: Biochemical and Histological Study.
Fingolimod and cardiac risk: latest findings and clinical implications.
Possible Relations Between Epstein-Barr Virus Past Infection and Classic Multiple Sclerosis in Guilan, Iran.
Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System.
Sharing data from MS clinical trials: Opportunities, challenges, and future directions.
Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population.
Overactive Bladder Syndrome, Detrusor Overactivity and the Botulinum Toxin.
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches.
Auditory function in children with Charcot-Marie-Tooth disease.
Real-World Assessment of Relapse, Medical Costs and Persistency of Multiple Sclerosis Patients Treated With Subcutaneous Interferon β-1a.
Neuronal gene transcription modulates demyelination and remyelination in a mouse model of multiple sclerosis.
Axon growth inhibition by RhoA/ROCK in the central nervous system.
Axon-to-Glia Interaction Regulates GabaA Receptor Expression in Oligodendrocytes.
Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
Neuroinflammation: A common denominator for stroke, multiple sclerosis and Alzheimer's disease.
Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study.
Pages
« first
‹ previous
…
707
708
709
710
711
712
713
714
715
…
next ›
last »